Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution

Blood

Volumn 113, Issue 22, 2009, Pages 5650-5659

  Kataru, Raghu P ^a   Jung, Keehoon ^a   Jang, Cholsoon ^a   Yang, Hanseul ^a   Schwendener, Reto A ^b   Jung, Eun Baik ^c   Seung, Hyun Han ^c,d   Alitalo, Kari ^e   Gou, Young Koh ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c BK 21 Plus   (South Korea)

^d International Vaccine Institute   (South Korea)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CYTOKERATIN 14; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; ANTIGEN; CHEMOKINE RECEPTOR; GR 1 PROTEIN, MOUSE; GR-1 PROTEIN, MOUSE; LIPOPOLYSACCHARIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DERMIS; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LYMPH FLOW; LYMPH NODE; LYMPH VESSEL; LYMPHANGIOGENESIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DERMATITIS; DRUG EFFECT; IMMUNOLOGY; LYMPHATIC SYSTEM DISEASE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS; ANTIGENS, CD11B; DERMATITIS; INFLAMMATION; LIPOPOLYSACCHARIDES; LYMPHANGIOGENESIS; LYMPHATIC DISEASES; LYMPHATIC VESSELS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, CHEMOKINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67049167170     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-09-176776     Document Type: Article

References (49)

1. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol. 2002;2:787-795. (Pubitemid 37328718)
2. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol. 2005;6:1191-1197. (Pubitemid 43045627)
3. Serhan CN, Brain SD, Buckley CD, et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 2007;21:325-332.
4. Lawrence T, Gilroy DW. Chronic inflammation: a failure of resolution? Inter J Exp Pathol. 2007;88:85-94.
5. Zhang X, Mosser DM. Macrophage activation by endogenous danger signals. J Pathol. 2008;214:161-178. (Pubitemid 351160154)
6. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113:1040-1050. (Pubitemid 38544126)
7. Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res. 2004;79:553-561. (Pubitemid 39223335)
8. Baluk P, Tammela T, Ator E, et al. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest. 2005;115:247-257. (Pubitemid 40385467)
9. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest. 2005;115:2316-2319.
10. Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115:2363-2372. (Pubitemid 41266198)
11. Kerjaschki D, Huttary N, Raab I, et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med. 2006;12:230-234. (Pubitemid 43214751)
12. + macrophages in malignant tumors and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis. J Pathol. 2006;209:67-77.
13. Maruyama K, Asai J, Ii M, Thorne T, LosordoDW, D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol. 2007;170:1178-1191. (Pubitemid 47339326)
14. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946-953.
15. Oliver G, Alitalo K. The lymphatic vasculature: recent progress and paradigms. Ann Rev Cell Devel Biol. 2005;21:457-483. (Pubitemid 41740643)
16. Ji RC. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Lymp Res Biol. 2006;4:83-100. (Pubitemid 44083659)
17. Cueni LN, Detmar M. New insights into the molecular control of the lymphatic vascular system and its role in disease. J Invest Dermatol. 2006;126:2167-2177. (Pubitemid 44413162)
18. Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis-impact on cancer metastasis. J Leukoc Biol. 2006;80:691-696. (Pubitemid 44835883)
19. Tammela T, Petrova TV, Alitalo K. Molecular lymphangiogenesis: new players. Trend Cell Biol. 2005;15:434-441.
20. Pullinger BD, Florey HW. Proliferation of lymphatics in inflammation. J Pathol Bacteriol. 1937;45:157-170.
21. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol. 2003;3:867-878.
22. Drayton DL, Liao S, Mounzer RH, Ruddle NH. Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol. 2006;7:344-353.
23. Liao S, Ruddle NH. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J Immunol. 2006;177:3369-3379. (Pubitemid 44277857)
24. Randolph GJ, Angeli V, Swartz MA. Dendritic cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol. 2005;5:617-628. (Pubitemid 41113193)
25. Angeli V, Ginhoux F, Llodra J, et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity. 2006;24:203-215. (Pubitemid 43214589)
26. Angeli V, Randolph GJ. Inflammation, lymphatic function, and dendritic cell migration. Lymp Res Biol. 2006;4:217-228. (Pubitemid 46493659)
27. Han SH, Kim JH, Martin M, Michalek SM, Naam MH. Pneumoccal Lipoteichoic acid (LTA) is not as potent as Staphylococcal LTA in stimulating Tool like receptor-2. Infect Immun. 2003;71:5541-5548. (Pubitemid 37205604)
28. Kim HJ, Yang JS, Woo SS, et al. Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines. J Leukoc Biol. 2007;81:983-989.
29. Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276:1423-1425. (Pubitemid 27235412)
30. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997;407:313-319.
31. Zeisberger SM, Odermatt B, Marty C, Zehnder-Fjallman AH, Ballmer-Hofer K, Schwendener RA. Clodronate-liposome-mediated depletion of tumor-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br J Cancer. 2006;95:272-281. (Pubitemid 44187587)
32. Mäkinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001;7:199-205. (Pubitemid 32148487)
33. Holash J, Davis S, Papadopoulos N, et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci U S A. 2002;99:11393-11398. (Pubitemid 34920936)
34. Jeon BH, Jang C, Han J, et al. Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. Cancer Res. 2008;68:1100-1109. (Pubitemid 351272228)
35. Koh YJ, Kang S, Lee HJ, et al. Bone marrow derived circulating progenitor cells fail to transdifferentiate into adipocytes in adult adipose tissues in mice. J Clin Invest. 2007;117:3684-3695. (Pubitemid 350224080)
36. Bellingan GJ, Cladwell H, Howie SEM, Dransfield I, Haslett C. In vivo fate of the inflammatory macrophage during the resolution of inflammation: inflammatory macrophages do not die locally, but emigrate to the draining lymph nodes. J Immunol. 1996;157:2577-2585.
37. Golpon HA, Fadok VA, Stewart LT, et al. Life after corpse engulfment: phogocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J. 2004;18:1716-1718.
38. Johnson LA, Clasper S, Holt AP, Lalor PF, Baban D, Jackson DG. An inflammation-induced mechanism for leukocyte transmigration across lymphatic vessel endothelium. J Exp Med. 2006;203:2763-2777. (Pubitemid 44833351)
39. Baluk P, Fuxe J, Hashizume H, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med. 2007;204:2349-2362. (Pubitemid 47529321)
40. Muller WA. New mechanisms and pathways for monocyte recruitment. J Exp Med. 2001;194:F47-F51.
41. Palframan RT, Jung S, Cheng G, et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med. 2001;194:1361-1373. (Pubitemid 33055053)
42. Janatpour MJ, Hudak S, Sathe M, Sedgwick JD, McEvoy LM. Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment. J Exp Med. 2001;194:1375-1384. (Pubitemid 33055054)
43. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood. 2007;109:1010-1017. (Pubitemid 46220646)
44. Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol. 2007;170:774-786. (Pubitemid 47339411)
45. Halin C, Tobler NE, Vigl B, Brown LF, Detmar M. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood. 2007;110:3158-3167. (Pubitemid 350106307)
46. Saaristo A, Tammela T, Timonen J, et al. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J. 2004;18:1707-1709. (Pubitemid 39561658)
47. Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008;11:109-119.
48. Xia Y-P, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 2003;102:161-168. (Pubitemid 36759650)
49. Nolan A, Weiden MD, Thurston G, Gold JA. Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis. Inflammation. 2004;28:271-278. (Pubitemid 41204378)